Literature DB >> 8814739

Risk factors for metastatic uveal melanoma after trans-scleral local resection.

B E Damato1, J Paul, W S Foulds.   

Abstract

AIMS: This study reports the metastatic death rate after trans-scleral local resection of uveal melanoma and identifies relevant risk factors.
METHODS: Local resection was performed in 332 patients (mean age 51 years), with follow up ranging to 20.9 years (median for living patients 33 months). The tumours had a mean largest basal diameter of 13.1 mm and mean thickness of 7.5 mm, with 135 containing epithelioid cells. Risk factors were identified by Cox analysis and metastatic rates demonstrated using Kaplan-Meier curves.
RESULTS: There were 52 deaths from metastatic melanoma. The significant risk factors were (i) age more than 60 years at treatment (p = 0.001), (ii) mixed/epithelioid tumours (p = 0.003), (iii) superior location of mixed/epithelioid tumours (over and above (ii)) (p = 0.001), (iv) largest basal tumour diameter of 16 mm or more (p < 0.001), (v) lack of adjunctive radiotherapy (p = 0.031), (vi) secondary enucleation for bulky residual/recurrent tumour (p = 0.002), and (vii) secondary enucleation for small residual/recurrent tumour extraocularly (p = 0.019). Metastatic death was not significantly associated with (i) incomplete tumour excision (p = 0.163), and (ii) small residual/recurrent tumour treated by enucleation (p = 0.855).
CONCLUSIONS: Survival diminished from 92% at 15 years if less than two risk factors were present to less than 30% in 3.5 years if more than three risk factors were present.

Entities:  

Mesh:

Year:  1996        PMID: 8814739      PMCID: PMC505400          DOI: 10.1136/bjo.80.2.109

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  37 in total

1.  Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

2.  The local excision of choroidal melanomata.

Authors:  W S Foulds
Journal:  Trans Ophthalmol Soc U K       Date:  1973

3.  Malignent melanomas of the human uvea. Recent follow-up of cases in Denmark, 1943-1952.

Authors:  O A Jensen
Journal:  Acta Ophthalmol (Copenh)       Date:  1970

4.  Ten years experience with eye wall resection for uveal malignant melanomas.

Authors:  G A Peyman; C P Juarez; J G Diamond; M Raichand
Journal:  Ophthalmology       Date:  1984-12       Impact factor: 12.079

5.  Prognosis in uveal melanoma with extrascleral extension.

Authors:  J C Affeldt; D S Minckler; S P Azen; L Yeh
Journal:  Arch Ophthalmol       Date:  1980-11

6.  Prognostic factors in choroidal and ciliary body melanomas.

Authors:  H F Shammas; F C Blodi
Journal:  Arch Ophthalmol       Date:  1977-01

7.  Prognostic factors in small malignant melanomas of choroid and ciliary body.

Authors:  M J McLean; W D Foster; L E Zimmerman
Journal:  Arch Ophthalmol       Date:  1977-01

8.  Metastatic choroidal melanoma.

Authors:  D H Char
Journal:  Am J Ophthalmol       Date:  1978-07       Impact factor: 5.258

9.  A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma.

Authors:  J M Seddon; D M Albert; P T Lavin; N Robinson
Journal:  Arch Ophthalmol       Date:  1983-12

10.  Pattern of mortality in choroidal malignant melanoma.

Authors:  R B Packard
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

View more
  20 in total

1.  Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

2.  Indications for trans-scleral local resection of uveal melanoma.

Authors:  B Damato; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

3.  Risk factors for residual and recurrent and metastatic uveal melanoma after trans-scleral local resection.

Authors:  W A Manschot
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

4.  Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture.

Authors:  B Damato
Journal:  Eye (Lond)       Date:  2012-06-29       Impact factor: 3.775

5.  Salvage proton beam therapy for recurrent iris melanoma: outcome and side effects.

Authors:  Aline I Riechardt; Julian P Klein; Dino Cordini; Jens Heufelder; Matus Rehak; Ira Seibel; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-20       Impact factor: 3.117

6.  Corneal autofluorescence in choroidal melanoma or in choroidal naevus.

Authors:  R P Müskens; J A Van Best; J C Bleeker; J E Keunen
Journal:  Br J Ophthalmol       Date:  2001-06       Impact factor: 4.638

7.  Eye-wall resection.

Authors:  D H Char; T Miller; J B Crawford
Journal:  Trans Am Ophthalmol Soc       Date:  2000

8.  Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.

Authors:  Alexander Böker; Daniel Pilger; Dino Cordini; Ira Seibel; Aline I Riechardt; Antonia M Joussen; Nikolaos E Bechrakis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-06-16       Impact factor: 3.117

9.  Exoresection via partial lamellar sclerouvectomy approach for uveal tumors: A successful performance by a novice surgeon.

Authors:  Rengin Aslihan Kurt; Kaan Gündüz
Journal:  Clin Ophthalmol       Date:  2010-02-02

10.  Exoresection and endoresection for uveal melanoma.

Authors:  Kaan Gündüz; Nikolaos E Bechrakis
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.